Scale Biosciences and Revvity’s BioLegend launched what they describe as a first-of-its-kind solution for high-parameter protein profiling of single cells. The TotalSeq™ Phenocyte™ single-cell protein profiling solution was designed to support customers by identifying and characterizing rare cell subtypes, which ultimately power immunology and oncology research. The solution is enabled by the proprietary combination of Scale Biosciences’ Quantum Barcoding technology platform and BioLegend’s TotalSeq antibody conjugates.
and
